METHODS OF ISOLATING T CELLS AND T CELL RECEPTORS HAVING ANTIGENIC SPECIFICITY FOR A CANCER-SPECIFIC MUTATION FROM PERIPHERAL BLOOD
Technology
E-149-2015
Patent ID
E-149-2015-0-US-06
Country
US
Application Type
DIV
Patent Status
Issued
Patent Number
11629334
Publication Number
US-2020-0095548-A1
Application Number
16/710,287
IC
NCI
Date Filed
Date Issued